CorMedix (CRMD) Return on Equity [ROE] (2010 - 2026)
CorMedix's Return on Equity [ROE] came in at 25.54% for Q2 2026, up 5.65 percentage points from 19.88% a year earlier.
Powered by 
Analysis
CorMedix (CRMD) Return on Equity [ROE] (2010 - 2026) Analysis & Trends
For FY2025, CorMedix's Return on Equity [ROE] was 0.69%, up 23.86 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +65.61 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -23.17% in FY2024 (+50.86 pp), -74.02% in FY2023 (-23.62 pp), -50.40% in FY2022 (+2.32 pp) and -52.72% in FY2021 (+12.19 pp).
- The five-year range for quarterly Return on Equity [ROE] is -101.94% (Q2 2024) to 48.66% (Q3 2025).
- Year-over-year, Return on Equity [ROE] increased in six of the last seven quarters, with an average year-over-year change of +60.86 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2025 (a gain of 136.65 percentage points), and the weakest in Q2 2024 (a drop of 30.27 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | CorMedix | 417.07 Mn | -222.82 Mn | 77.13 Mn | -7.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.25% |
| Mar 31, 2026 | -7.25% |
| Dec 31, 2025 | -4.13% |
| Sep 30, 2025 | -0.88% |
| Jun 30, 2025 | 19.89% |
| Mar 31, 2025 | 17.22% |
| Dec 31, 2024 | -25.00% |
| Sep 30, 2024 | -87.96% |
| Jun 30, 2024 | -101.94% |
| Mar 31, 2024 | -78.41% |
| Dec 31, 2023 | -60.45% |
| Sep 30, 2023 | -60.15% |
| Jun 30, 2023 | -71.61% |
| Mar 31, 2023 | -60.93% |
| Dec 31, 2022 | -53.35% |
| Sep 30, 2022 | -49.70% |
| Jun 30, 2022 | -51.08% |
| Mar 31, 2022 | -45.78% |
| Dec 31, 2021 | -42.72% |
| Sep 30, 2021 | -36.27% |
API Access
CorMedix Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();